Glenmark Generics Inc. (GGI), USA is the North American division of Glenmark Generics Ltd. (GGL) dedicated to the manufacture, marketing and distribution of generic pharmaceutical products. Read more.

Glenmark commenced its European operations in the UK in 2004. The generic formulations and API business in Europe has a robust product portfolio developed by a Europe-dedicated R&D team and has excellent supply chain resources. Read more.

Glenmark Generics Argentina is the hub for generic research, manufacturing and distribution of oncology products for the whole world. The company’s continuous growth since then now spans 23 countries. Read More.

Glenmark API is the Active Pharmaceutical Ingredient manufacturing arm of Glenmark Generics. With a presence in over 80 countries Glenmark's API business is among the top 10 in the Indian Generic Pharmaceutical Market. Read more.

June 25, 2009:Glenmark Generics receives ANDA approval from the U.S. FDA for Alclometasone Dipropionate Cream Read More

June 01, 2009: Glenmark receives ANDA approval from U.S. FDA for Hydralazine Hydrochloride Tablets Read More